MCMedicalCodingSoftware
J0643

J0643: Injection, leucovorin calcium, not otherwise specified, 1 mg

HCPCSActiveBETOS O1E

J0643 is a HCPCS Level II code for injection, leucovorin calcium, not otherwise specified, 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

The CMS record for J0643

Long descriptor
Injection, leucovorin calcium, not otherwise specified, 1 mg

The official wording. This is what the code means.

Short descriptor
Inj leucovorin calcium 1 mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
October 1, 2026

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J0643

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J0643 is not quite right, the correct code is very often within a few positions of it.

  • J0620Injection, calcium glycerophosphate and calcium lactate, per 10 ml
  • J0630Injection, calcitonin salmon, up to 400 units
  • J0636Injection, calcitriol, 0.1 mcg
  • J0637Injection, caspofungin acetate, 5 mg
  • J0638Injection, canakinumab, 1 mg
  • J0640Injection, leucovorin calcium, per 50 mgterminated
  • J0641Injection, levoleucovorin, not otherwise specified, 0.5 mg
  • J0642Injection, levoleucovorin (khapzory), 0.5 mg
  • J0644Injection, leucovorin calcium (avyxa), 1 mg
  • J0650Injection, levothyroxine sodium, not otherwise specified, 10 mcg
  • J0651Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg
  • J0652Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg
  • J0654Injection, liothyronine, 1 mcg
  • J0665Injection, bupivicaine, not otherwise specified, 0.5 mg
  • J0666Injection, bupivacaine liposome, 1 mg
  • J0668Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
HCPCS Level II2026Q4-Oct· effective October 1, 2026